DH — Definitive Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- $417.36m
- $533.14m
- $252.20m
- 58
- 70
- 31
- 53
Annual cashflow statement for Definitive Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -51.2 | -61.3 | -24.2 | -290 | -591 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 16.4 | 30.7 | 39.8 | 328 | 667 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.59 | -4.85 | -19.2 | -30.4 | -25.9 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 23.2 | 25.2 | 35.6 | 41.2 | 58.2 |
| Capital Expenditures | -1.4 | -6.73 | -8.33 | -2.98 | -12.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -22.5 | -40 | -241 | -28.8 | -14.1 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -23.9 | -46.7 | -249 | -31.8 | -26.4 |
| Financing Cash Flow Items | -3.17 | -24.8 | -19.8 | -17 | -20.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.7 | 384 | -26.7 | -25.6 | -56.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.2 | 363 | -241 | -16 | -25.6 |